Dashboard
Manage Tickers

MREOMereo BioPharma Group plc

Nasdaq mereobiopharma.com


$ 3.59 $ 0.14 (4.06 %)    

Wednesday, 03-Jul-2024 12:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 3.59
$ 3.41
$ 3.59 x 373
$ 0.00 x 0
$ 3.41 - $ 3.60
$ 1.07 - $ 4.50
298,573
na
2.51B
$ 1.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

leerink-partners-maintains-outperform-on-mereo-biopharma-group-raises-price-target-to-8
Leerink Partners Maintains Outperform on M...
06/20/2024 12:08:34

Leerink Partners analyst Joseph Schwartz maintains Mereo BioPharma Group (NASDAQ:MREO) with a Outperform and raises the pric...

mereo-biopharma-discloses-pricing-of-50m-underwritten-registered-direct-offering-of-american-depository-shares-at-a-price-of-399-per-ads-each-ads-represents-five-ordinary-shares-of-mereo
Mereo BioPharma Discloses Pricing of $50M ...
06/14/2024 11:54:43

baird-initiates-coverage-on-mereo-biopharma-group-with-outperform-rating-announces-price-target-of-8
Baird Initiates Coverage On Mereo BioPharm...
06/13/2024 09:17:24

Baird analyst Jack Allen initiates coverage on Mereo BioPharma Group (NASDAQ:MREO) with a Outperform rating and announces P...

why-streamline-health-solutions-shares-are-trading-lower-by-23-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Streamline Health Solutions Shares Are...
06/12/2024 17:25:48

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:16:08

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

uber-to-rally-around-38-here-are-10-top-analyst-forecasts-for-wednesday
Uber To Rally Around 38%? Here Are 10 Top ...
06/12/2024 12:01:17

needham-maintains-buy-on-mereo-biopharma-group-raises-price-target-to-7
Needham Maintains Buy on Mereo BioPharma G...
06/12/2024 10:37:56

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and raises the price target from $6 to $7.

why-oracle-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket
Why Oracle Shares Are Trading Higher By 9%...
06/12/2024 09:33:47

Core News & Articles
Ultragenyx, Mereo Report 14-Month Results ...
06/11/2024 21:53:19

As of a May 24, 2024 data cut-off date, treatment with setrusumab (UX143) continued to significantly reduce incidence of fractu...

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/16/2024 15:07:07

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

needham-reiterates-buy-on-mereo-biopharma-group-maintains-6-price-target
Needham Reiterates Buy on Mereo BioPharma ...
05/16/2024 11:23:26

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $6 price target.

mereo-biopharma-group-q1-2024-adj-eps-001
Mereo BioPharma Group Q1 2024 Adj EPS $(0.01)
05/15/2024 20:23:26

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/29/2024 12:06:58

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
04/24/2024 20:31:44

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

needham-reiterates-buy-on-mereo-biopharma-group-maintains-6-price-target
Needham Reiterates Buy on Mereo BioPharma ...
04/10/2024 10:11:51

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $6 price target.

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
03/28/2024 14:22:43

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

needham-maintains-buy-on-mereo-biopharma-group-raises-price-target-to-6
Needham Maintains Buy on Mereo BioPharma G...
03/28/2024 10:05:04

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and raises the price target from $5 to $6.

mereo-biopharma-group-fy-eps-004-up-from-007-yoy-sales-1000m
Mereo BioPharma Group FY EPS $(0.04) Up Fr...
03/27/2024 20:21:17

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losse...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)